Advertisement

Infection

, Volume 9, Issue 5, pp 220–222 | Cite as

Serotypes and antimicrobial susceptibility of Streptococcus pneumoniae in west Germany

  • D. Milatović
  • K. Machka
  • W. Heck
  • I. Braveny
Article

Summary

Two-hundred-and-six strains ofStreptococcus pneumoniae were isolated in eight centers in West Germany. The prevalent serotypes were: 19, 3, 6, 7, 23 and 15. Seventy-five percent of the strains tested were antigenically identical to the pneumococcal types included in the 14-valent vaccine Pneumovax®. Susceptibility testing revealed resistance to tetracycline (11% of the isolates), co-trimoxazole (7%) and chloramphenicol (2%). Seven percent of the isolates were relatively resistant to penicillin (MIC 0.1–1.0 mg/l).

Keywords

Public Health Internal Medicine Infectious Disease Penicillin General Practice 

Serotypen und Resistenzverhalten von Streptococcus pneumoniae in der Bundesrepublik Deutschland

Zusammenfassung

In einer multizentrischen Studie wurden insgesamt 206 Stämme vonStreptococcus pneumoniae aus acht Instituten in der Bundesrepublik Deutschland untersucht. Die vorherrschenden Serotypen waren 19, 3, 6, 7, 23 und 15. 75% aller isolierten Stämme besitzen das Antigen, das auch in der 14 Polysaccharid-Antigene umfassenden Vakzine Pneumovax® enthalten ist. Bei der Bestimmung der minimalen Hemmkonzentration zeigten 11% der Isolate Resistenz gegen Tetracyclin, 7% gegen Co-Trimoxazol und 2% gegen Chloramphenicol. 7% der Stämme zeigten eine relative Resistenz gegenüber Penicillin (MHK 0,1–1,0 mg/l).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature

  1. 1.
    Austrian, R. Random gleanings from a life with thepneumococcus. J. Infect. Dis. 131 (1975) 474–484.CrossRefPubMedGoogle Scholar
  2. 2.
    Hansman, D., Bullen, M. M. A resistantpneumococcus. Lancet 1 (1967) 264–265.CrossRefGoogle Scholar
  3. 3.
    Hansman, D. Type distribution and antibiotic sensitivity ofDiplococcus pneumoniae. A five year study in Sydney. Med. J. Aust. 2 (1974) 436–440.PubMedGoogle Scholar
  4. 4.
    Cybulska, J., Jeljaszewicz, J., Lund, E., Munksgaard, A. Prevalence of types ofDiplococcus pneumoniae and their susceptibility to 30 antibiotics. Chemotherapy 15 (1970) 304–316.CrossRefPubMedGoogle Scholar
  5. 5.
    Cooksey, R. C., Facklam, R. R., Thornsberry, C. Antimicrobial susceptibility patterns ofStreptococcus pneumoniae. Antimicrob. Agents Chemother. 13 (1978) 645–648.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Ahronheim, G. A., Reich, B., Marks, M. J. Penicillin-insensitive pneumococci. Am. J. Dis. Child. 133 (1979) 187–191.CrossRefPubMedGoogle Scholar
  7. 7.
    Appelbaum, P. C., Bhamjee, A., Seragg, J. N., Hallett, A. F., Bowen, A. J., Cooper, R. C. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet II (1977) 995–997.CrossRefGoogle Scholar
  8. 8.
    Jacobs, M. R., Koornhof, H. J., Robins-Browne, R. M., Stevenson, C. M., Vermaak, Z. A., Freiman, J., Miller, G. B., Witcomb, M. A., Isaacson, M., Ward, J. J., Austrian, R. Emergence of multiply resistant pneumococci. N. Engl. J. Med. 229 (1978) 735–740.CrossRefGoogle Scholar
  9. 9.
    Cates, K. L., Gerrard, J. M., Giebink, G. S., Lund, M. E., Bleeker, E. Z., Lau, S., O'Leary, M. C., Krivit, W., Quie, P. G. A penicillin-resistantpneumococcus. J. Pediatr. 93 (1978) 624–626.CrossRefPubMedGoogle Scholar
  10. 10.
    Braveny, I. In vitro activity of cefaclor againstH. influenzae in comparison to other oral antibiotics. Infection 7 Suppl. 6 (1979) S 532-S 535.CrossRefGoogle Scholar
  11. 11.
    Weber, F., Kayser, F. H. Antimikrobielle Resistenz und Serotypen vonStreptococcus pneumoniae in der Schweiz. Schweiz. Med. Wschr. 109 (1979) 395–399.PubMedGoogle Scholar
  12. 12.
    Goldstein, F. W., Dang-Van, A., Bouanchaud, D. H., Acar, J. F. Evolution de la résistance aux antibiotiques des pneumocoques et répartition de leurs types capsulaires. Pathol. Biol. 26 (1978) 173–180.PubMedGoogle Scholar
  13. 13.
    Watanakunakorn, C., Glotzbecker, C. Susceptibility of recent clinical isolates ofStreptococcus pneumoniae to 17 antibiotics. J. Antimicrob. Chemother. 6 (1980) 83–89.CrossRefPubMedGoogle Scholar
  14. 14.
    Naraqi, S., Kirkpatrick, G. P., Kabins, S. Relapsingpneumococcal meningitis: isolation of an organism with decreased susceptibility to penicillin G. J. Pediatr. 85 (1974) 671–673.CrossRefPubMedGoogle Scholar
  15. 15.
    Paredes, A., Taber, L. H., Yow, M. D., Clark, D., Nathan, W. Prolonged pneumococcal meningitis due to an organism with increased resistance to penicillin. Pediatrics 58 (1976) 378–381.PubMedGoogle Scholar
  16. 16.
    Hince, C. J., Howard, A. J. Serotypes ofStreptococcus pneumoniae in the United Kingdom. Current Chemotherapy. Proc. 10th Int. Congr. Chemother. Zürich 1 (1978) 543–545.Google Scholar
  17. 17.
    Lund, E., Pulverer, G., Jeljaszewicz, J. Serological types ofDiplococcus pneumoniae strains isolated in Germany. Comparison with type patterns in other countries. Med. Microbiol. Immunol. 159 (1974) 171–178.CrossRefGoogle Scholar
  18. 18.
    Riley, J. D., Andrews, M., Howard, R., Tarr, P. J., Pfeiffer, M., Challands, P., Jennison, G., Douglas, R. M. Immunisation with a polyvalent pneumococcal vaccine. Lancet II (1977) 1338–1341.CrossRefGoogle Scholar
  19. 19.
    Smit, P., Oberholzer, D., Hayden-Smith, S., Koornhof, H. J., Hilleman, M. R. Protective efficacy of pneumococcal polysaccharide vaccines. J. Am. Med. Ass. 238 (1977) 1613–1616.CrossRefGoogle Scholar

Copyright information

© MMW Medizin Verlag 1981

Authors and Affiliations

  • D. Milatović
    • 1
  • K. Machka
    • 1
  • W. Heck
    • 1
  • I. Braveny
    • 1
  1. 1.Institut für Medizinische Mikrobiologie und Hygiene der Technischen Universität MünchenMünchen 80

Personalised recommendations